{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:09:49Z","timestamp":1785798589514,"version":"3.56.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:p>Very limited experimental and clinical data are currently available regarding the cerebrospinal fluid (CSF) penetration of ceftazidime-avibactam in adults. Nevertheless, up to our knowledge, there are no data of ceftazidime-avibactam use in central nervous system infections in pediatric patients. For that, here we describe our experience with the use of ceftazidime-avibactam in addition to intraventricular colistin in a pediatric patient diagnosed with ventriculoperitoneal shunt infection due to multidrug-resistant <jats:italic toggle=\"yes\">P. aeruginosa<\/jats:italic>. A 2-year-old boy known to pre-term, delivered at 26 weeks with hydrocephalus that required ventriculoperitoneal shunt which was infected due to <jats:italic toggle=\"yes\">P. aeruginosa.<\/jats:italic> He was treated with multiple antipseudomonal agents; however, cultures remained persistently positive. On day 54 of admission, the isolate was reported as multidrug-resistant <jats:italic toggle=\"yes\">P. aeruginosa<\/jats:italic> and he was switched to ceftazidime-avibactam and intraventricular colistin. CSF cultures became sterile 3 days after initiation of this antibiotic regimen, and subsequent CSF cultures had no growth. No recurrent episode of central nervous system infections due to <jats:italic toggle=\"yes\">P. aeruginosa<\/jats:italic> occurred up to 2 years of follow-up.<\/jats:p>","DOI":"10.1097\/inf.0000000000003439","type":"journal-article","created":{"date-parts":[[2021,12,27]],"date-time":"2021-12-27T03:00:41Z","timestamp":1640574041000},"page":"436-438","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":14,"title":["Ceftazidime-avibactam for the Treatment of Multidrug-resistant Pseudomonas aeruginosa Central Nervous System Infection in Pediatric Patient: A Case Report"],"prefix":"10.1097","volume":"41","author":[{"given":"Thamer A.","family":"Almangour","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Alsubaie","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Diseases Unit, Department of Pediatric, College of Medicine, King Saud University, King Saud University Medical City, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leen","family":"Ghonem","sequence":"additional","affiliation":[{"name":"Clinical pharmacist-Infectious Diseases Services, King Saud University Medical City, Kingdom of Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hissah A.","family":"Almohaini","sequence":"additional","affiliation":[{"name":"PGY1 Pharmacy Practice Resident, Pharmacy Services, King Saud University Medical City, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hind","family":"Mohammed Bakheet","sequence":"additional","affiliation":[{"name":"Pediatric infectious diseases unit, department of Pediatric, King Saud University Medical City, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikhlass","family":"Altweijri","sequence":"additional","affiliation":[{"name":"Pediatric Neurosurgery, Department of Surgery, College of Medicine, King Saud University, King Saud University Medical City, Riyadh, Saudi Arabia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,12,21]]},"reference":[{"key":"R3-20250615","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S1473-3099(16)30004-4","article-title":"Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study.","volume":"16","author":"Carmeli","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"R4-20250615","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1473-3099(17)30747-8","article-title":"Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial.","volume":"18","author":"Torres","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"R5-20250615","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1093\/cid\/ciw133","article-title":"Efficacy and safety of ceftazidime-avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infection: results from a randomized, controlled, double-blind, phase 3 program.","volume":"62","author":"Mazuski","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R8-20250615","doi-asserted-by":"crossref","first-page":"ofaa349","DOI":"10.1093\/ofid\/ofaa349","article-title":"Using therapeutic drug monitoring to treat KPC-producing Klebsiella pneumoniae central nervous system infection with Ceftazidime\/Avibactam.","volume":"7","author":"Yasmin","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"R9-20250615","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"R11-20250615","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/cid\/ciw243","article-title":"Ceftazidime\/Avibactam and Ceftolozane\/Tazobactam: second-generation \u03b2-Lactam\/\u03b2-Lactamase inhibitor combinations.","volume":"63","author":"van Duin","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R12-20250615","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1128\/AAC.00220-16","article-title":"In Vitro susceptibility of global surveillance isolates of pseudomonas aeruginosa to ceftazidime-avibactam (INFORM 2012 to 2014).","volume":"60","author":"Nichols","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"R13-20250615","doi-asserted-by":"crossref","first-page":"e00875","DOI":"10.1128\/AAC.00875-17","article-title":"Multicenter evaluation of ceftazidime-avibactam and ceftolozane-tazobactam inhibitory activity against meropenem-nonsusceptible pseudomonas aeruginosa from blood, respiratory tract, and wounds.","volume":"61","author":"Grupper","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"R14-20250615","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/cts.12585","article-title":"Ceftazidime-avibactam population pharmacokinetic modeling and pharmacodynamic target attainment across adult indications and patient subgroups.","volume":"12","author":"Li","year":"2019","journal-title":"Clin Transl Sci"},{"key":"R15-20250615","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/jac\/dkx358","article-title":"Ceftazidime\/avibactam use for carbapenem-resistant Klebsiella pneumoniae meningitis: a case report.","volume":"73","author":"Holyk","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"suppl_1","key":"R16-20250615","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw172.885","article-title":"Ceftazidime-Avibactam for the treatment of post-neurosurgical meningitis caused by a Klebsiella pneumoniae carbapenemase (KPC)-Producing Klebsiella pneumoniae.","volume":"3","author":"Samuel","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"R17-20250615","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jgar.2018.07.010","article-title":"Evaluation of ceftazidime\/avibactam for serious infections due to multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa.","volume":"15","author":"Rodr\u00edguez-N\u00fa\u00f1ez","year":"2018","journal-title":"J Glob Antimicrob Resist"},{"key":"R18-20250615","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ijantimicag.2016.11.005","article-title":"Clinical experience with ceftazidime\/avibactam in patients with severe infections, including meningitis and lung abscesses, caused by extensively drug-resistant Pseudomonas aeruginosa.","volume":"49","author":"Xipell","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"R19-20250615","doi-asserted-by":"crossref","first-page":"953","DOI":"10.2146\/ajhp170632","article-title":"Successful treatment of ventriculitis caused by Pseudomonas aeruginosa and carbapenem-resistant Klebsiella pneumoniae with i.v. ceftazidime-avibactam and intrathecal amikacin.","volume":"75","author":"Gofman","year":"2018","journal-title":"Am J Health Syst Pharm"},{"key":"R20-20250615","doi-asserted-by":"crossref","first-page":"e13082","DOI":"10.1111\/tid.13082","article-title":"Successful ceftazidime-avibactam treatment of post-surgery Burkholderia multivorans genomovar II bacteremia and brain abscesses in a young lung transplanted woman with cystic fibrosis.","volume":"21","author":"Dacc\u00f2","year":"2019","journal-title":"Transpl Infect Dis"},{"key":"R21-20250615","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1086\/425368","article-title":"Practice guidelines for the management of bacterial meningitis.","volume":"39","author":"Tunkel","year":"2004","journal-title":"Clin Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003439","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T16:04:33Z","timestamp":1750003473000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,21]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000003439","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,21]]}}}